Royal Bank of Canada
CLLS

Royal Bank of Canada’s Cellectis CLLS Stock Holding History

Royal Bank of Canada’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56
Closed – – 7164
2023
Q3 		$0 Hold
56
– – ﹤0.01% 7131
2023
Q2 		$0 Sell
56
-9
-14% -$17 ﹤0.01% 7295
2023
Q1 		$0 Hold
65
– – ﹤0.01% 7108
2022
Q4 		$0 Buy
65
+9
+16% +$20 ﹤0.01% 7271
2022
Q3 		$0 Sell
56
-52
-48% -$158 ﹤0.01% 7484
2022
Q2 		$0 Buy
108
+18
+20% +$63 ﹤0.01% 7399
2022
Q1 		$0 Sell
90
-4,886
-98% -$26.9K ﹤0.01% 7765
2021
Q4 		$41K Sell
4,976
-8,835
-64% -$86.8K ﹤0.01% 6479
2021
Q3 		$175K Buy
13,811
+7,053
+104% +$97.7K ﹤0.01% 5288
2021
Q2 		$105K Sell
6,758
-408
-6% -$6.86K ﹤0.01% 5570
2021
Q1 		$146K Buy
7,166
+1,926
+37% +$47.6K ﹤0.01% 5170
2020
Q4 		$142K Sell
5,240
-12,983
-71% -$291K ﹤0.01% 5110
2020
Q3 		$337K Buy
18,223
+13,895
+321% +$247K ﹤0.01% 4166
2020
Q2 		$77K Buy
4,328
+3,228
+293% +$49.1K ﹤0.01% 5008
2020
Q1 		$10K Hold
1,100
– – ﹤0.01% 5823
2019
Q4 		$19K Sell
1,100
-150
-12% -$2K ﹤0.01% 5866
2019
Q3 		$13K Sell
1,250
-719
-37% -$9.67K ﹤0.01% 5673
2019
Q2 		$30K Buy
1,969
+293
+17% +$5.23K ﹤0.01% 5506
2019
Q1 		$31K Buy
1,676
+45
+3% +$798 ﹤0.01% 5414
2018
Q4 		$26K Buy
1,631
+531
+48% +$12.3K ﹤0.01% 5449
2018
Q3 		$31K Buy
1,100
+495
+82% +$14.2K ﹤0.01% 5452
2018
Q2 		$17K Sell
605
-1,611
-73% -$48K ﹤0.01% 5603
2018
Q1 		$70K Buy
2,216
+1,836
+483% +$58K ﹤0.01% 4884
2017
Q4 		$11K Hold
380
– – ﹤0.01% 5821
2017
Q3 		$11K Sell
380
-515
-58% -$13.3K ﹤0.01% 6222
2017
Q2 		$23K Buy
895
+725
+426% +$17.3K ﹤0.01% 5481
2017
Q1 		$4K Hold
170
– – ﹤0.01% 6271
2016
Q4 		$3K Sell
170
-1,000
-85% -$18.5K ﹤0.01% 6404
2016
Q3 		$28K Hold
1,170
– – ﹤0.01% 5409
2016
Q2 		$31K Sell
1,170
-100
-8% -$2.93K ﹤0.01% 5312
2016
Q1 		$35K Buy
1,270
+1,100
+647% +$26.5K ﹤0.01% 5275
2015
Q4 		$5K Buy
170
+70
+70% +$2.12K ﹤0.01% 6144
2015
Q3 		$3K Hold
100
– – ﹤0.01% 6295
2015
Q2 		$4K Buy
+100
New +$3.51K ﹤0.01% 6273

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada's CLLS Position: Q4 2023 in Review

Royal Bank of Canada sold out of Cellectis (CLLS) in Q4 2023, closing a stake of 56 shares.

Royal Bank of Canada first reported a position in CLLS in Q2 2015 and held it in 34 quarters. The position peaked at $337K in Q3 2020. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2023.

  • Royal Bank of Canada reported no remaining Cellectis position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 56 Cellectis shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Cellectis in Q2 2015 and held it in 34 quarters.
  • Royal Bank of Canada's Cellectis position peaked at $337K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.